This issue was best addressed in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial of 1235 patients with hypertension (>130/80 mmHg) and type 2 diabetes; all patients were treated with an ACE inhibitor or ARB, while other antihypertensive drugs were discontinued [69].